Imaging to detect impaired microcirculatory reperfusion after clot removal
Official title: Image Detection of Impaired Microcirculatory Reperfusion
Run by University of Cincinnati · NCT07099599 · Data updated 2026-11-12
This project tests whether CT perfusion scans done after clot removal can spot poor tiny-vessel blood flow in adults with large-vessel ischemic stroke.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Status | Recruiting |
| Started | September 30, 2024 |
| Main results expected | March 31, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | August 1, 2025 |
| Trial ID | NCT07099599 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with anterior-circulation large-vessel occlusion treated with mechanical thrombectomy who achieve mTICI 2c/3 reperfusion within 24 hours of last known normal and who can undergo contrast CT perfusion are the ideal candidates.
✕Probably not a fit
Patients with severe renal insufficiency, contraindications to iodinated contrast or MRI, tandem occlusions, prior significant ipsilateral stroke, more than four clot retrieval attempts, pregnancy, incarceration, or enrollment in other acute interventional stroke trials are unlikely to qualify or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
ID IMR is a single-center, prospective feasibility observational effort using post-thrombectomy CT perfusion to find a radiographic biomarker of impaired microcirculatory reperfusion (IMR) after angiographic reperfusion. The study enrolls adults with anterior-circulation large-vessel occlusion who achieve near-complete or complete reperfusion (mTICI 2c/3) following mechanical thrombectomy within 24 hours of last known normal. Investigators analyze CT perfusion patterns and related clinical variables to identify imaging features that predict infarct expansion despite successful vessel opening. The best-performing imaging biomarker from this cohort will be validated in a larger prospective study as a surrogate marker of IMR.
Why it matters
Potential benefit: If successful, this could let clinicians identify patients who remain at high risk of brain tissue damage despite successful clot removal and target them for additional treatments or closer monitoring.
How similar studies have gone: Microvascular 'no-reflow' after thrombectomy is a recognized phenomenon and small imaging studies have suggested patterns on perfusion scans, but a validated radiographic biomarker for IMR remains novel and unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults greater than or equal to 18 years of age * Last known normal (LKN) within 24 hours * Ischemic stroke due to anterior circulation LVO (intracranial internal carotid artery \[ICA\], proximal middle cerebral artery \[M1\], M1/M2 bifurcation, or proximal dominant M2 occlusion) * mTICI2c or mTICI3 on digital subtracted angiography (DSA) following mechanical thrombectomy Exclusion Criteria: * Significant renal insufficiency (glomerular filtration rate \<30mg/ml/min2 while not on dialysis) * Contraindication to iodinated contrast * Contraindication to magnetic resonance imaging (e.g., pacemaker incompatibility) * Prior significant stroke in same vascular territory ipsilateral stroke * Tandem vessel occlusion (i.e., extracranial ICA and ipsilateral intracranial M1/M2 occlusion) * Greater than 4 clot retrieval attempts * Enrollment in another acute stroke interventional study (with the exception of thrombectomy device registries) * Pregnancy * Prisoners
Where it's running
-
University of Cincinnati
Cincinnati, Ohio, United States Recruiting
Study contacts
- Study coordinator: Yasmin N Aziz, MD
- Email: azizyn@ucmail.uc.edu
- Phone: 513-688-5405
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sevoflurane vs. Propofol for anesthesia in stroke patients undergoing clot-removal
This study tests whether sevoflurane or propofol used for anesthesia during endovascular treatment of an acute ischemic stroke affects the final brain damage and recovery.
-
AI-powered decision support to boost thrombolysis for ischemic stroke
This trial tests whether an AI-assisted decision tool helps doctors give intravenous thrombolysis to eligible ischemic stroke patients within 24 hours at a primary hospital in China, compared with standard care.
-
Tenecteplase or Reteplase Bridging Before Thrombectomy in Acute Ischemic Stroke
This trial tests whether giving tenecteplase or reteplase before mechanical thrombectomy helps people with acute ischemic stroke due to large vessel occlusion, compared with doing thrombectomy alone.
-
Intra-arterial Alteplase after successful reperfusion following mechanical thrombectomy
This trial tests whether giving a small amount of alteplase directly into the artery after a successful thrombectomy helps adults with acute ischemic stroke recover better.
-
Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy
This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.
-
Intra-arterial Thrombolysis for Acute Ischemic Stroke with Medium Vessel Occlusion
This trial tests whether delivering a clot-busting medicine directly into the brain’s medium vessels helps improve outcomes for adults with acute ischemic stroke caused by MeVO, on top of standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.